| __timestamp | Ascendis Pharma A/S | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13983000 | 52602000 |
| Thursday, January 1, 2015 | 8118000 | 105812000 |
| Friday, January 1, 2016 | 4606000 | 113485000 |
| Sunday, January 1, 2017 | 1530000 | 285461000 |
| Monday, January 1, 2018 | 10581000 | 141726000 |
| Tuesday, January 1, 2019 | 13375000 | 150446000 |
| Wednesday, January 1, 2020 | 6953000 | 224227000 |
| Friday, January 1, 2021 | 4255000 | 361897000 |
| Saturday, January 1, 2022 | 39037000 | 520812000 |
| Sunday, January 1, 2023 | 222323000 | 636892000 |
| Monday, January 1, 2024 | 319383000 | 855907000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, Ascendis Pharma A/S and Halozyme Therapeutics, Inc. have showcased intriguing financial trajectories over the past decade. From 2014 to 2023, Halozyme Therapeutics consistently outperformed Ascendis Pharma in terms of gross profit, with a remarkable 1,110% increase, peaking at $637 million in 2023. In contrast, Ascendis Pharma experienced a more modest growth of 1,490%, reaching $222 million in the same year. This stark difference highlights Halozyme's strategic prowess in capitalizing on market opportunities. Notably, both companies saw significant growth in 2022, with Ascendis Pharma's gross profit surging by 900% and Halozyme's by 44% compared to the previous year. As the biotech industry continues to evolve, these financial insights provide a glimpse into the dynamic strategies and market positions of these two innovative companies.
Gross Profit Trends Compared: Novartis AG vs Halozyme Therapeutics, Inc.
Who Generates Higher Gross Profit? Pfizer Inc. or Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Sanofi vs Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Ascendis Pharma A/S
Alnylam Pharmaceuticals, Inc. and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Bio-Techne Corporation and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Ascendis Pharma A/S vs Grifols, S.A.
Ascendis Pharma A/S and Alkermes plc: A Detailed Gross Profit Analysis
Gross Profit Comparison: Ascendis Pharma A/S and MorphoSys AG Trends
Gross Profit Comparison: Ascendis Pharma A/S and Amphastar Pharmaceuticals, Inc. Trends
Gross Profit Analysis: Comparing Jazz Pharmaceuticals plc and Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Halozyme Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.